IL-4-loaded alginate/chitosan multilayer films for promoting angiogenesis through both direct and indirect means
暂无分享,去创建一个
[1] Zhenjiang Ma,et al. Evaluation of Interleukin-4-Loaded Sodium Alginate-Chitosan Microspheres for Their Support of Microvascularization in Engineered Tissues. , 2021, ACS biomaterials science & engineering.
[2] J. Weng,et al. Alginate/chitosan modified immunomodulatory titanium implants for promoting osteogenesis in vitro and in vivo. , 2021, Materials science & engineering. C, Materials for biological applications.
[3] F. O'Brien,et al. In vitro vascularization of tissue engineered constructs by non-viral delivery of pro-angiogenic genes. , 2021, Biomaterials science.
[4] S. Levenberg,et al. Macrophages of diverse phenotypes drive vascularization of engineered tissues , 2020, Science Advances.
[5] J. Weng,et al. Alginate/chitosan multilayer films coated on IL-4-loaded TiO2 nanotubes for modulation of macrophage phenotype. , 2019, International journal of biological macromolecules.
[6] Jichun Liu,et al. Nanotubular TiO2 regulates macrophage M2 polarization and increases macrophage secretion of VEGF to accelerate endothelialization via the ERK1/2 and PI3K/AKT pathways , 2019, International journal of nanomedicine.
[7] T. Skaria,et al. IL-4 Causes Hyperpermeability of Vascular Endothelial Cells through Wnt5A Signaling , 2016, PloS one.
[8] M. Ferrari,et al. IL-4 Release from a Biomimetic Scaffold for the Temporally Controlled Modulation of Macrophage Response , 2016, Annals of Biomedical Engineering.
[9] G. Vunjak‐Novakovic,et al. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. , 2014, Biomaterials.
[10] D. Mooney,et al. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. , 2013, Biomaterials.
[11] Liping Tang,et al. Dual growth factor releasing multi-functional nanofibers for wound healing. , 2013, Acta biomaterialia.
[12] A. Nagy,et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. , 2012, Blood.
[13] Narutoshi Hibino,et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] T. Wynn,et al. Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.
[15] Didier Y. R. Stainier,et al. Molecular control of endothelial cell behaviour during blood vessel morphogenesis , 2011, Nature Reviews Molecular Cell Biology.
[16] Won Hee Lee,et al. Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium , 2010, Inflammation Research.
[17] Y. Hayashi,et al. The Local Injection of Peritoneal Macrophages Induces Neovascularization in Rat Ischemic Hind Limb Muscles , 2008, Cell transplantation.
[18] J. Lavoie,et al. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[19] Y. Ikada,et al. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells. , 2005, Biomaterials.
[20] N. Klein,et al. Interleukin‐4 increases the permeability of human endothelial cells in culture , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[21] J. Ambati,et al. Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[22] R. Pakala,et al. Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. , 2002, Cardiovascular radiation medicine.
[23] Y. Iwamoto,et al. The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13 , 2000, The Journal of Immunology.
[24] T. Shono,et al. Novel biological functions of interleukin-4: formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo. , 1998, Biochemical and biophysical research communications.
[25] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[26] N Klein,et al. Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. , 1996, International immunology.
[27] B. Ryffel,et al. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. , 1996, Blood.
[28] E. Shevach,et al. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. , 1996, Immunology today.
[29] R. Callard,et al. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. , 1993, International immunology.
[30] W. Paul,et al. Interleukin-4 : A Prototypic Immunoregulatory Lymphokine , 2003 .
[31] Gordana Vunjak-Novakovic,et al. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. , 2015, Biomaterials.
[32] S. Verbruggen,et al. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo , 2013, Angiogenesis.
[33] Won Hee Lee,et al. Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium. , 2010, Cytokine.
[34] K. Chen,et al. Gene Expression Profile in Interleukin-4-Stimulated Human Vascular Endothelial Cells , 2004, Molecular medicine.
[35] Yong Woo Lee,et al. Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells. , 2003, American journal of physiology. Heart and circulatory physiology.
[36] Y. W. Lee,et al. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. , 2001, Journal of molecular and cellular cardiology.
[37] A. Manning,et al. TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells , 1996 .
[38] K. Schulze-Osthoff,et al. Macrophage-derived angiogenesis factors. , 1991, Pharmacology & therapeutics.